Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
Nishijima-Futami Y, Minami S, Futami S, Koba T, Higashiguchi M, Tamiya M, Suzuki H, Hirashima T, Komuta K, Kijima T. Nishijima-Futami Y, et al. Among authors: futami s. Cancer Chemother Pharmacol. 2017 Jun;79(6):1215-1220. doi: 10.1007/s00280-017-3321-x. Epub 2017 Apr 28. Cancer Chemother Pharmacol. 2017. PMID: 28455584 Clinical Trial.
Emergency department visits after hours by lung cancer patients in Japan.
Minami S, Yamamoto S, Ogata Y, Takeuchi Y, Hamaguchi M, Koba T, Futami S, Nishijima Y, Komuta K. Minami S, et al. Among authors: futami s. Support Care Cancer. 2013 Sep;21(9):2443-51. doi: 10.1007/s00520-013-1814-7. Epub 2013 Apr 18. Support Care Cancer. 2013. PMID: 23595560
Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital.
Fujimoto K, Minami S, Yamamoto S, Ogata Y, Koba T, Futami S, Nishijima Y, Yaga M, Masuhiro K, Komuta K. Fujimoto K, et al. Among authors: futami s. Support Care Cancer. 2014 Jun;22(6):1485-92. doi: 10.1007/s00520-013-2105-z. Epub 2014 Jan 12. Support Care Cancer. 2014. PMID: 24414996
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
Koba T, Minami S, Nishijima-Futami Y, Masuhiro K, Kimura H, Futami S, Yaga M, Mori M, Kagawa H, Uenami T, Kohmo S, Otsuka T, Yamamoto S, Komuta K, Kijima T. Koba T, et al. Among authors: futami s. Cancer Chemother Pharmacol. 2018 Jul;82(1):111-117. doi: 10.1007/s00280-018-3598-4. Epub 2018 May 4. Cancer Chemother Pharmacol. 2018. PMID: 29728800 Clinical Trial.
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis.
Osa A, Uenami T, Naito Y, Hirata H, Koyama S, Takimoto T, Shiroyama T, Futami S, Nakatsubo S, Sawa N, Yano Y, Nagatomo I, Takeda Y, Mori M, Kida H, Kumanogoh A. Osa A, et al. Among authors: futami s. Thorac Cancer. 2019 Nov;10(11):2183-2187. doi: 10.1111/1759-7714.13197. Epub 2019 Sep 14. Thorac Cancer. 2019. PMID: 31520515 Free PMC article.
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles.
Futami Y, Takeda Y, Koba T, Narumi R, Nojima Y, Ito M, Nakayama M, Ishida M, Yoshimura H, Naito Y, Fukushima K, Takimoto T, Edahiro R, Matsuki T, Nojima S, Hirata H, Koyama S, Iwahori K, Nagatomo I, Shirai Y, Suga Y, Satoh S, Futami S, Miyake K, Shiroyama T, Inoue Y, Adachi J, Tomonaga T, Ueda K, Kumanogoh A. Futami Y, et al. Among authors: futami s. Int Immunol. 2022 Jun 4;34(6):327-340. doi: 10.1093/intimm/dxac009. Int Immunol. 2022. PMID: 35294531 Free PMC article.
143 results